Treatment Use of Domperidone for Gastroparesis
NCT02227927 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2025-06-29
Summary
Domperidone is a drug that may be of benefit to individuals with gastroesophageal reflux disease (GERD), with upper GI symptoms, gastroparesis, and chronic constipation.
This is a long-term treatment program for prescription of this drug to all patients who, in the investigators' judgement, could benefit from its use.
Conditions
- Gastroesophageal Reflux Disease
- GERD
- Gastroparesis
Interventions
- DRUG
-
Domperidone
10-30mg oral dose, four times daily.
Sponsors & Collaborators
-
Scott Gabbard, MD
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity
NCT02140073 ·Status: UNKNOWN ·Phase: PHASE4
-
Gastroesophageal Reflux Treatment in Scleroderma
NCT01878526 ·Status: COMPLETED ·Phase: PHASE3
-
GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals
NCT02584751 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease
NCT00587522 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial for 'Shen Qu Xiao Shi' Oral Liquid in the Treatments of Children's Functional Dyspepsia
NCT05030116 ·Status: COMPLETED ·Phase: PHASE4
-
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
NCT06329583 ·Status: COMPLETED ·Phase: NA
-
Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
NCT06778824 ·Status: RECRUITING ·Phase: NA
-
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
NCT02972047 ·Status: COMPLETED ·Phase: NA
-
Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing
NCT00537732 ·Status: TERMINATED ·Phase: PHASE4
-
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT01472939 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
The Mechanism Versus PPI Trial
NCT06999577 ·Status: RECRUITING ·Phase: PHASE4
-
Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)
NCT00246909 ·Status: COMPLETED ·Phase: PHASE4
-
A New System for GERD Diagnosis and Treatment
NCT03600974 ·Status: UNKNOWN
-
A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD
NCT00575822 ·Status: TERMINATED ·Phase: NA
-
An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux
NCT02749071 ·Status: TERMINATED ·Phase: NA
-
The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers
NCT02736734 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Usefulness and Influence on Esophageal Motility of Pyridostigmine for Dysphagia in Systemic Sclerosis
NCT06915181 ·Status: WITHDRAWN ·Phase: PHASE2
-
Endoloop Mediated Cardioplication to Treat Gastroesophageal Reflux Disease
NCT06153901 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.
NCT00171457 ·Status: COMPLETED ·Phase: PHASE3
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
Registry Study of the NDO Surgical Plicator for the Treatment of GERD
NCT00597792 ·Status: TERMINATED ·Phase: NA
-
The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease
NCT00915616 ·Status: WITHDRAWN ·Phase: PHASE3
-
Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial
NCT02486263 ·Status: COMPLETED ·Phase: NA
-
Influence of Shenqu Xiaoshi Oral Liquid on Intestinal Microbiome of Children With Functional Dyspepsia
NCT05515887 ·Status: COMPLETED ·Phase: PHASE4